Taysha Gene Therapies, Inc.

Contributing Author

Recent Articles by Taysha Gene Therapies, Inc.

Jun-06	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) TSHA GlobeNewswire
Jun-03	Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program TSHA GlobeNewswire
May-28	Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants TSHA GlobeNewswire
May-28	Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants TSHA GlobeNewswire
May-28	Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102 TSHA GlobeNewswire
May-15	Taysha Gene Therapies Reports First Quarter 2025 Financial Results and Provides Corporate Update TSHA GlobeNewswire
May-08	Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15 TSHA GlobeNewswire
May-02	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) TSHA GlobeNewswire